Wolfgang Klietmann, M.D. is a clinical pathologist and medical microbiologist and is an appointed lecturer at the faculty of Harvard Medical School. Until 2001 Klietmann served on the staff of the Department of Pathology at the Massachusetts General Hospital. He performed research work as an Associate Scientist at the Wistar Institute of the University of Pennsylvania. For five years he headed a research group at the Max-Planck-Institute for Virus Research and served on the medical faculty of the University of Tuebingen (Germany). Klietmann was Founder, President, and Physician-in-Chief of a leading Institute of Laboratory Medicine in Germany, which was successfully bought out by the pharmaceutical industry. During his professional career he has evaluated the efficacy and side effects of several major vaccines and has performed recently work in biodefense together with MIT for the DoD. Klietmann serves on the board of directors of the Harvard Business School Health Industry Alumni Association and has co-chaired several annual healthcare conferences of the association. He is a member of the scientific advisory board of BioCal Technology, Inc.